Press Releases - 2022-11-10

Date	Title	Company
10-Nov-2022	Global Cochlear Implants Growth, Trends, Absolute Opportunity and Value Chain 2022-2030\|Cochlear, MED-EL, AB(Sonova)	Wired Release
10-Nov-2022	Teeth Whitening Market is expected to reach US$ 10.7 Billion by 2032 – Exclusive Report by FMI	MARKITWIRED
10-Nov-2022	Global Endotoxin Testing Segments, Opportunity, Growth and Forecast By End-use Industry 2022-2030\|Lonza, Pacific BioLabs, Charles River	Wired Release
10-Nov-2022	Global Enthesopathy Treatment Market Global Trends, Regulations and Competitive Landscape Outlook to 2030\|Abbott Laboratories, Accuray Incorporated, Boston Scientific	Wired Release
10-Nov-2022	Global Cloud Technologies in Healthcare Growth, Trends, Absolute Opportunity and Value Chain 2022-2030\|Athenahealth, CareCloud Corporation, VMware	Wired Release
10-Nov-2022	RHÖN-KLINIKUM AG closes first nine months of 2022 with revenue surplus	RHÖN-KLINIKUM Aktiengesellschaft
10-Nov-2022	How the patent medicine market is becoming a driving force in healthcare	Wired Release
10-Nov-2022	Iron Supplement Market To Power And Cross USD 3.02 billion By 2031	Wired Release
10-Nov-2022	Medios AG continues growth course in the first nine months of 2022 – guidance for the 2022 financial year confirmed	Medios AG
10-Nov-2022	APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill pipeline to achieve medium-term targets	APONTIS PHARMA AG
10-Nov-2022	Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil	Evolva Holding SA
10-Nov-2022	SYNLAB AG: SYNLAB reports strong underlying performance in 9M 2022, confirms 2022 guidance and releases 2023 guidance	SYNLAB AG
10-Nov-2022	Isoniazid Market to Hit USD 976.6 Million, Globally, by 2031 at 5.9% CAGR	Wired Release
10-Nov-2022	Blepharitis Treatment Market worth USD 1.8 billion by 2031 – Exclusive Report by Market.us	Wired Release
10-Nov-2022	Dong-A ST signe un accord de licence portant sur le biosimilaire NESP®, DA-3880, avec la société turque Polifarma	Businesswire
10-Nov-2022	Dong-A ST unterzeichnet Lizenzvertrag mit türkischer Polifarma für NESP® Biosimilar DA-3880	Businesswire